CD274 and cancer: Even among tumor-infiltrating T cells, tumor and immune cells expressing PD-L1 can inhibit neighboring PD-1+ T cells through the PD-1/PD-L1 axis, an immune checkpoint that cancer cells can exploit to inhibit antitumor immune responses (20).